-
3
-
-
0032485439
-
-
Hulme, C.; Morrissette, M. M.; Volz, F. A.; Burns, C. J. Tetrahedron Lett. 1998, 39, 1113.
-
(1998)
Tetrahedron Lett
, vol.39
, pp. 1113
-
-
Hulme, C.1
Morrissette, M.M.2
Volz, F.A.3
Burns, C.J.4
-
5
-
-
0346970836
-
-
Rikimaru, K.; Yanagisawa, A.; Kan, T.; Fukuyama, T. Synlett 2004, 41.
-
(2004)
Synlett
, pp. 41
-
-
Rikimaru, K.1
Yanagisawa, A.2
Kan, T.3
Fukuyama, T.4
-
6
-
-
34248580122
-
-
(a) Isaacson, J.; Gilley, C. B.; Kobayashi, Y. J. Org. Chem. 2007, 72, 3913.
-
(2007)
J. Org. Chem
, vol.72
, pp. 3913
-
-
Isaacson, J.1
Gilley, C.B.2
Kobayashi, Y.3
-
10
-
-
33748324475
-
-
(b) Veljkovic, I.; Zimmer, R.; Reissig, H.-U.; Bruedgam, I.; Hartl, H. Synthesis 2006, 2677.
-
(2006)
Synthesis
, pp. 2677
-
-
Veljkovic, I.1
Zimmer, R.2
Reissig, H.-U.3
Bruedgam, I.4
Hartl, H.5
-
11
-
-
0026377826
-
-
Baraldi, P. G.; Cacciari, B.; Leoni, A.; Recanatini, M.; Roberti, M.; Rossi, M.; Manfredini, S.; Periotto, V.; Simoni, D. Farmaco 1991, 46, 1337.
-
(1991)
Farmaco
, vol.46
, pp. 1337
-
-
Baraldi, P.G.1
Cacciari, B.2
Leoni, A.3
Recanatini, M.4
Roberti, M.5
Rossi, M.6
Manfredini, S.7
Periotto, V.8
Simoni, D.9
-
12
-
-
0033377205
-
-
Baraldi, P. G.; Cacciari, B.; Romagnoli, R.; Spalluto, G. Arzneim.-Forsch. 1999, 49, 997.
-
(1999)
Arzneim.-Forsch
, vol.49
, pp. 997
-
-
Baraldi, P.G.1
Cacciari, B.2
Romagnoli, R.3
Spalluto, G.4
-
13
-
-
0028556273
-
-
(a) Baraldi, P. G.; Leoni, A.; Cacciari, B.; Manfredini, S.; Simoni, D.; Bergomi, M.; Menta, E.; Spinelli, S. J. Med. Chem. 1994, 37, 4329.
-
(1994)
J. Med. Chem
, vol.37
, pp. 4329
-
-
Baraldi, P.G.1
Leoni, A.2
Cacciari, B.3
Manfredini, S.4
Simoni, D.5
Bergomi, M.6
Menta, E.7
Spinelli, S.8
-
14
-
-
0027759396
-
-
(b) Baraldi, P. G.; Leoni, A.; Cacciari, B.; Manfredini, S.; Simoni, D. Bioorg. Med. Chem. Lett. 1993, 3, 2511.
-
(1993)
Bioorg. Med. Chem. Lett
, vol.3
, pp. 2511
-
-
Baraldi, P.G.1
Leoni, A.2
Cacciari, B.3
Manfredini, S.4
Simoni, D.5
-
15
-
-
0023720294
-
-
Baraldi, P. G.; Casolari, A.; Manfredini, S.; Periotto, V.; Zanirato, V.; Florio, C.; Traversa, V.; Bertelli, G. M.; Borea, P. A. Arzneim.-Forsch. 1988, 38, 1262.
-
(1988)
Arzneim.-Forsch
, vol.38
, pp. 1262
-
-
Baraldi, P.G.1
Casolari, A.2
Manfredini, S.3
Periotto, V.4
Zanirato, V.5
Florio, C.6
Traversa, V.7
Bertelli, G.M.8
Borea, P.A.9
-
17
-
-
62349100521
-
-
Other reaction conditions that were screened and proved inefficient for post-MCR cyclization of 3 included conventional heating in AcOH, conventional and microwave heating in TFA, as well as using base promoters (KOt-Bu, NaH) in various solvents (e.g., THF, DMF, dioxane). tert-Butyl isonitrile was chosen on the basis of its commercial availability in large quantities. However, we are also finding it superior to other isocyanides in the present post-MCR cyclization. These finding will be disclosed in a separate communication.
-
Other reaction conditions that were screened and proved inefficient for post-MCR cyclization of 3 included conventional heating in AcOH, conventional and microwave heating in TFA, as well as using base promoters (KOt-Bu, NaH) in various solvents (e.g., THF, DMF, dioxane). tert-Butyl isonitrile was chosen on the basis of its commercial availability in large quantities. However, we are also finding it superior to other isocyanides in the present post-MCR cyclization. These finding will be disclosed in a separate communication.
-
-
-
-
18
-
-
62349111527
-
-
Parallel evaporation of volatiles from the microwave reactor tube was carried out using GeneVac® equipment
-
Parallel evaporation of volatiles from the microwave reactor tube was carried out using GeneVac® equipment.
-
-
-
-
19
-
-
62349130427
-
-
No further purification and characterization (except LC-MS analysis) of the crude Ugi reaction products 3 were performed.
-
No further purification and characterization (except LC-MS analysis) of the crude Ugi reaction products 3 were performed.
-
-
-
-
20
-
-
62349119241
-
-
Characterization Data for Selected Compounds Compound 2f: white solid, mp 122-123°C. 1H NMR (300 MHz, CDCl3, δ, 7.58 (s, 1 H, 7.50-7.55 (t, J, 8.1 Hz, 1 H, 7.27-7.31 (m, 2 H, 7.19-7.24 (m, 1 H, 7.08-7.13 (m, 3 H, 7.00 (ddd, J, 8.4, 2.5, 1.0 Hz, 1 H, 6.89 (d, J, 8.4 Hz, 2 H, 5.63 (d, J, 14.5 Hz, 1 H, 5.58 (s, 1 H, 3.87 (s, 3 H, 3.82 (s, 3 H, 3.45 (d, J, 14.5 Hz, 1 H, 2.38 (s, 3 H, 13C NMR (75Hz, CDCl3, δ, 160.2, 159.7, 159.3, 158.1, 154.3, 138.0, 137.3, 132.1, 131.5, 131.1, 129.8, 129.5, 129.1, 126.6, 126.3, 125.7, 119.1, 116.4, 114.1, 111.1, 110.4, 60.6, 55.0, 54.9, 45.6, 19.2. LC-MS: m/z, 433 [M, H, Anal. Calcd for C 28H25N3O4: C, 71.93; H, 5.39; N, 8.99. Found: C, 72.04; H, 5.43; N, 9.02. Compound 2i: beige solid, mp 152-153°C (decomp, 1H NMR 300 MHz, CDCl3, δ
-
2S: C, 65.50; H, 3.50; N, 10.47. Found: C, 65.54; H, 3.60; N, 10.51.
-
-
-
|